|
1
|
Geiger TR and Peeper DS: Metastass
mechanisms. Biochim Biophys Acta. 1796:293–308. 2009.PubMed/NCBI
|
|
2
|
Miller KD, Siegel RL, Lin CC, Mariotto AB,
Kramer JL, Rowland JH, Stein KD, Alteri R and Jemal A: Cancer
treatment and survivorship statistics, 2016. CA Cancer J Clin.
66:271–289. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cabioglu N, Gong Y, Islam R, Broglio KR,
Sneige N, Sahin A, Gonzalez-Angulo AM, Morandi P, Bucana C,
Hortobagyi GN and Cristofanilli M: Expression of growth factor and
chemokine receptors: New insights in the biology of inflammatory
breast cancer. Ann Oncol. 18:1021–1029. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu W, Qian L, Chen X and Ding B:
Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients
with breast cancer. Int J Clin Exp Pathol. 8:13217–13224.
2015.PubMed/NCBI
|
|
5
|
Fernandis AZ, Prasad A, Band H, Klösel R
and Ganju RK: Regulation of CXCR4-mediated chemotaxis and
chemoinvasion of breast cancer cells. Oncogene. 23:157–167. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mukherjee D, Lu H, Yu L, He C, Lahiri SK,
Li T and Zhao J: Kruppel-like factor 8 activates the transcription
of C-X-C cytokine receptor type 4 to promote breast cancer cell
invasion, transendothelial migration and metastasis. Oncotarget.
7:23552–23568. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang EH, Singh B, Cristofanilli M,
Gelovani J, Wei C, Vincent L, Cook KR and Lucci A: A CXCR4
antagonist CTCE-9908 inhibits primary tumor growth and metastasis
of breast cancer. J Surg Res. 155:231–236. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liang Z, Yoon Y, Votaw J, Goodman MM,
Williams L and Shim H: Silencing of CXCR4 blocks breast cancer
metastasis. Cancer Res. 65:967–971. 2005.PubMed/NCBI
|
|
9
|
Katkoori VR, Basson MD, Bond VC, Manne U
and Bumpers HL: Nef-M1, a peptide antagonist of CXCR4, inhibits
tumor angiogenesis and epithelialtomesenchymal transition in colon
and breast cancers. Oncotarget. 6:27763–27777. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen R, Qiu W, Liu Z, Cao X, Zhu T, Li A,
Wei Q and Zhou J: Identification of JWA as a novel functional gene
responsive to environmental oxidative stress induced by
benzo[a]pyrene and hydrogen peroxide. Free Radic Biol Med.
42:1704–1714. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang S, Shen Q, Mao WG, Li AP, Ye J, Liu
QZ, Zou CP and Zhou JW: JWA, a novel signaling molecule, involved
in the induction of differentiation of human myeloid leukemia
cells. Biochem Biophys Res Commun. 341:440–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou J, Ye J, Zhao X, Li A and Zhou J: JWA
is required for arsenic trioxide induced apoptosis in HeLa and
MCF-7 cells via reactive oxygen species and mitochondria linked
signal pathway. Toxicol Appl Pharmacol. 230:33–40. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shen L, Xu W, Li A, Ye J and Zhou J: JWA
enhances As2O3-induced tubulin polymerization
and apoptosis via p38 in HeLa and MCF-7 cells. Apoptosis.
16:1177–1193. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu W, Chen Q, Wang Q, Sun Y, Wang S, Li A,
Xu S, Røe OD, Wang M, Zhang R, et al: JWA reverses cisplatin
resistance via the CK2-XRCC1 pathway in human gastric cancer cells.
Cell Death Dis. 5:e15512014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wei B, Han Q, Xu L, Zhang X, Zhu J, Wan L,
Jin Y, Qian Z, Wu J, Gao Y, et al: Effects of JWA, XRCC1 and BRCA1
mRNA expression on molecular staging for personalized therapy in
patients with advanced esophageal squamous cell carcinoma. BMC
Cancer. 15:3312015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen H, Bai J, Ye J, Liu Z, Chen R, Mao W,
Li A and Zhou J: JWA as a functional molecule to regulate cancer
cells migration via MAPK cascades and F-actin cytoskeleton. Cell
Signal. 19:1315–1327. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bai J, Zhang J, Wu J, Shen L, Zeng J, Ding
J, Wu Y, Gong Z, Li A, Xu S, et al: JWA regulates melanoma
metastasis by integrin alphaVbeta3 signaling. Oncogene.
29:1227–1237. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen Y, Huang Y, Huang Y, Xia X, Zhang J,
Zhou Y, Tan Y, He S, Qiang F, Li A, et al: JWA suppresses tumor
angiogenesis via Sp1-activated matrix metalloproteinase-2 and its
prognostic significance in human gastric cancer. Carcinogenesis.
35:442–451. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lu J, Tang Y, Farshidpour M, Cheng Y,
Zhang G, Jafarnejad SM, Yip A, Martinka M, Dong Z, Zhou J, et al:
JWA inhibits melanoma angiogenesis by suppressing ILK signaling and
is an independent prognostic biomarker for melanoma.
Carcinogenesis. 34:2778–2788. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou J, Ge Z, Tan Y, Jiang G, Feng J, Wang
H and Shi G: Downregulation of JWA expression in human esophageal
squamous cell carcinoma and its clinical significance. Oncol Res.
20:157–162. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu X, Chen H, Gao Q, Bai J, Wang X, Zhou
J, Qiu S, Xu Y, Shi Y, Wang X, et al: Downregulation of JWA
promotes tumor invasion and predicts poor prognosis in human
hepatocellular carcinoma. Mol Carcinog. 53:325–336. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lim RC, Price JT and Wilce JA:
Context-dependent role of Grb7 in HER2+ve and triple-negative
breast cancer cell lines. Breast Cancer Res Treat. 143:593–603.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Peng Y, Zhong Y and Li G: Tubeimoside-1
suppresses breast cancer metastasis through downregulation of CXCR4
chemokine receptor expression. BMB Rep. 49:502–507. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lian X, Jiao Y, Yang Y, Wang Z, Xuan Q,
Liu H, Lu S, Wang Z, Liu Y, Li S, et al: CrkL regulates
SDF-1-induced breast cancer biology through balancing Erk1/2 and
PI3K/Akt pathways. Med Oncol. 32:4112015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lin J, Ma T, Jiang X, Ge Z, Ding W, Wu Y,
Jiang G, Feng J, Cui G and Tan Y: JWA regulates human esophageal
squamous cell carcinoma and human esophageal cells through
different mitogen-activated protein kinase signaling pathways. Exp
Ther Med. 7:1767–1771. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lu J, Tang Y, Cheng Y, Zhang G, Yip A,
Martinka M, Dong Z, Zhou J and Li G: ING4 regulates JWA in
angiogenesis and their prognostic value in melanoma patients. Br J
Cancer. 109:2842–2852. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qian J, Zhu W, Wang K, Ma L, Xu J, Xu T,
Røe OD, Li A, Zhou J and Shu Y: JWA loss promotes cell migration
and cytoskeletal rearrangement by affecting HER2 expression and
identifies a high-risk subgroup of HER2-positive gastric carcinoma
patients. Oncotarget. 7:36865–36884. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen X, Feng J, Ge Z, Chen H, Ding W, Zhu
W, Tang X, Chen Y, Tan Y and Ma T: Effects of the JWA gene in the
regulation of human breast cancer cells. Mol Med Rep. 11:3848–3853.
2015. View Article : Google Scholar : PubMed/NCBI
|
